aclens.com - Acuvue Contact Lenses for Less    Shop Warby Parker Online   



Planned Spin-Off Will Allow Alcon to Better Focus on Growth Strategies, CEO Endicott Says

FORT WORTH, Texas—The “new” Alcon that emerges from a planned spin-off from Novartis (NYSE: NVS) in the first half of 2019 will look much like “a $7 billion start-up” with a rapt focus on innovation and R&D as it attempts to address ongoing changes in the delivery of eyecare, chief executive officer David Endicott said this week at the company’s Innovation for Better Vision session....


J&J Cites Pharmaceutical Segment for Driving a 10.6 Percent Increase in Second-Quarter Sales

NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) on Tuesday reported that its sales rose 10.6 percent to $20.8 billion in the second quarter, due in part to a 19.9 percent sales increase in its pharmaceutical business segment. On an operational basis, the company’s overall sales increase was 8.7 percent, and the positive impact of currency was 1.9 percent, according to the announcement. Domestic sales increased 9.4 percent, while international sales rose 11.8 percent, reflecting operational gro...


Alcon’s New CEO Endicott Says Eyecare Company Is Committed to Fort Worth

FORT WORTH, Texas—Alcon expects to build upon its 70 years of history in this Texas metro area following its spinoff from parent company Novartis in 2019, the eyecare group’s new chief executive officer has said. “Fort Worth is where Alcon was born more than 70 years ago, and we look forward to building on our legacy here following the proposed spinoff,” chief executive officer David Endicott said in a statement to the Star-Telegram of Fort Worth earlier this week....


SynergEyes Appoints Bob Ferrigno as CEO; Prepares to Boost Specialty Business

CARLSBAD, Calif.—The board of directors of SynergEyes, Inc. has appointed Bob Ferrigno as chief executive officer, effective June 27....


Bausch + Lomb Announces Licensing Agreement With Tangible Science for Use of Custom Contact Lens Coating Technology

BRIDGEWATER, N.J.—Bausch + Lomb, a leading global eye health company, announced that it has entered into a worldwide licensing agreement with Tangible Science, LLC, a company whose mission is to create technologies that improve the contact lens wearing experience....


SynergEyes and Brien Holden Vision Institute Partner on Contact Lens Development

CARLSBAD, Calif.—SynergEyes, a leading hybrid specialty contact lens company, announced a new partnership with the Brien Holden Vision Institute,  the leading translational vision correction center which delivers advanced, customized vision correction for myopes and presbyopes. The exclusive worldwide licensing agreement will enable the manufacturing of design technologies developed by Brien Holden Vision Institute, augmenting the SynergEyes presbyopic package by offering the latest designs on t...


Contact Lenses News:

Planned Spin-Off Will Allow Alcon to Better Focus on Growth Strategies, CEO Endicott Says

FORT WORTH, Texas—The “new” Alcon that emerges from a planned spin-off from Novartis (NYSE: NVS) in the first half of 2019 will look much like “a $7 billion start-up” with a rapt focus on innovation and R&D as it attempts to address ongoing changes in the delivery of eyecare, chief executive officer David Endicott said this week at the company’s Innovation for Better Vision session....


J&J Cites Pharmaceutical Segment for Driving a 10.6 Percent Increase in Second-Quarter Sales

NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) on Tuesday reported that its sales rose 10.6 percent to $20.8 billion in the second quarter, due in part to a 19.9 percent sales increase in its pharmaceutical business segment. On an operational basis, the company’s overall sales increase was 8.7 percent, and the positive impact of currency was 1.9 percent, according to the announcement. Domestic sales increased 9.4 percent, while international sales rose 11.8 percent, reflecting operational gro...


Alcon’s New CEO Endicott Says Eyecare Company Is Committed to Fort Worth

FORT WORTH, Texas—Alcon expects to build upon its 70 years of history in this Texas metro area following its spinoff from parent company Novartis in 2019, the eyecare group’s new chief executive officer has said. “Fort Worth is where Alcon was born more than 70 years ago, and we look forward to building on our legacy here following the proposed spinoff,” chief executive officer David Endicott said in a statement to the Star-Telegram of Fort Worth earlier this week....


SynergEyes Appoints Bob Ferrigno as CEO; Prepares to Boost Specialty Business

CARLSBAD, Calif.—The board of directors of SynergEyes, Inc. has appointed Bob Ferrigno as chief executive officer, effective June 27....


Bausch + Lomb Announces Licensing Agreement With Tangible Science for Use of Custom Contact Lens Coating Technology

BRIDGEWATER, N.J.—Bausch + Lomb, a leading global eye health company, announced that it has entered into a worldwide licensing agreement with Tangible Science, LLC, a company whose mission is to create technologies that improve the contact lens wearing experience....


SynergEyes and Brien Holden Vision Institute Partner on Contact Lens Development

CARLSBAD, Calif.—SynergEyes, a leading hybrid specialty contact lens company, announced a new partnership with the Brien Holden Vision Institute,  the leading translational vision correction center which delivers advanced, customized vision correction for myopes and presbyopes. The exclusive worldwide licensing agreement will enable the manufacturing of design technologies developed by Brien Holden Vision Institute, augmenting the SynergEyes presbyopic package by offering the latest designs on t...


SKU-B24-886 Soflens Daily Disposable for Astigmatism from 1 800 get lens  sku

Soflens Daily Disposable for Astigmatism - B24-886 by Bausch & Lomb

Item description: This Contact Lenses Toric Lenses product is by Bausch & Lomb - The first daily disposable for Astigmatism design to reduce spherical aberration. SofLens-« daily disposable Toric for Astigmatism combines Bausch & Lomb's highly reputed, scientific heritage in toric technology with the convenience of a daily disposable lens.... Learn More

Manufacturer: Bausch & Lomb

Keywords: Soflens Daily Disposable for Astigmatism Bausch & Lomb Toric Lenses

1-800-GET-LENS

Store: We provide customers with top brands like Bausch&Lomb and Johnson&Johnson - brands that customers know and trust.

Category: Toric Lenses

$23.99

See the Price of Soflens Daily Disposable for Astigmatism

You may also consider:

  Biotrue ONEday
Biotrue ONEday lenses are made from a next generation, bio-inspired material called HyperGel for comfortable vision throughout the day.The outer surface of the lens is designed to mimic the lipid layer of tear film to prevent dehydration and maintain consistent Optics. It features the same water content as the cornea, 78%, to support incredible comfort and allows oxygen to flow freely through the lens, without the need for silicone, delivering oxygen level the open eye needs to maintain healthy, ...See The Price
 
  ULTRA
Bausch + Lomb ULTRA contact lenses with MoistureSeal technology - helps prevent lens dehydration that may be caused by reduced blink rates. Bausch and Lomb's Ultra lens is made from a new silicone hydrogel material, with excellent oxygen permeability. ...See The Price
 
  Biotrue ONEday for Presbyopia
Biotrue ONEday for Presbyopia's revolutionary new 3-Zone Progressive design helps you see clearly and comfortably with your contacts, close up, far away, and everywhere in between, with a convenient daily disposable modality. Plus the breakthrough lens material works like the eye's own healthy tears to retain the same moisture level as the natural eye - for comfort throughout the day. ...See The Price